Endovascular treatmenT for Acute Ischemic Stroke in China

NCT04752735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-02-10

No results posted yet for this study

Summary

This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

Conditions

  • Stroke
  • Endovascular Treatment

Interventions

OTHER

endovascular treatment

all enrolled patients must receive endovascular treatment.

Sponsors & Collaborators

  • General Hospital of Shenyang Military Region

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-22
Primary Completion
2023-02-08
Completion
2023-02-08

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04752735 on ClinicalTrials.gov